Leonard DA(1)(2)(3), Powell HR(1), Defazio MW(1), Shanmugarajah K(1)(2), Mastroianni M(1)(2), Rosales IA(4), Farkash EA(4), Colvin RB(4), Randolph MA(2), Sachs DH(1)(5), Kurtz JM(1)(6), Cetrulo CL Jr(1)(2)(7). Author information:
(1)Center for Transplantation Sciences, Harvard Medical School, Massachusetts
General Hospital, Boston, Massachusetts, USA.
(2)Division of Plastic and Reconstructive Surgery, Massachusetts General
Hospital, Boston, Massachusetts, USA.
(3)Canniesburn Plastic Surgery Unit, Glasgow Royal Infirmary, Glasgow, Scotland.
(4)Department of Pathology, Massachusetts General Hospital, Boston,
(5)Columbia Center for Translational Immunology, Columbia University Medical
Center, New York, New York, USA.
(6)Department of Biology, Emmanuel College, Boston, Massachusetts, USA.
(7)Shriners Hospital for Children, Boston, Massachusetts, USA.
Vascularized composite allografts (VCAs) can restore fully functional anatomic units in patients with limb amputations or severe facial tissue loss. However, acute rejection of the skin is frequently observed and underscores the importance of developing tolerance induction protocols. In this study, we have characterized the skin immune system in VCAs. We demonstrate infiltration of recipient leukocytes, regardless of rejection status, and in tolerant mixed hematopoietic chimeras, the co-existence of these cells with donor leukocytes in the absence of rejection. Here we characterize the dermal T cell and epidermal Langerhans cell components of the skin immune system in our porcine model of VCA tolerance, and the kinetics of cutaneous chimerism in both of these populations in VCAs transplanted to tolerant and nontolerant recipients, as well as in host skin. Furthermore, in biopsies from the first patient to receive a hand transplant in our program, we demonstrate the presence of recipient T cells in the skin of the transplanted limb in the absence of clinical or histological evidence of rejection.
Having over 250 Research scholars worldwide and more than 400 articles online with open access.